Interaction between α1 antitrypsin and lymphocyte surface proteases: immunoregulatory effects
Authors:
- 1 June 1981
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 11 (6-7) , 614-616
Abstract
Alpha 1 antitrypsin (α1-AT) is the major plasma protease inhibitor. Radioiodinated α1-AT binds to human lymphocytes. The binding is fast and reversible, and the cells can be saturated with a maximum of approximately 1.2×106 molecules of α1-AT per lymphocyte. The receptor for α1-AT is a surface-associated protease. Adition of α1-AT completely inhibits cell surface proteolytic activity. Furthermore α1-AT decreases3H-thymidine incorporation into lymphocytes stimulated by B or T cell mitogens or by allogeneic cells. Since α1-AT was shown to be produced by activated monocytes and to bind to lymphocytes, it is likely to represent a mediator of monocyte-lymphocyte interactions.Keywords
This publication has 18 references indexed in Scilit:
- Binding of alpha 1 antitrypsin (α1 protease inhibitor) to human lymphocytesBiochemical and Biophysical Research Communications, 1981
- α1-Antitrypsin is an effector of immunological stasisNature, 1978
- Effects of the antiprotease Trasylol® on peripheral blood leucocytesCellular and Molecular Life Sciences, 1978
- Effect of protease inhibitors on mitogen stimulation of hamster lymphoid cellsExperimental Cell Research, 1976
- Stimulation of a subpopulation of hamster lymphoid cells by trypsin and chymotrypsinExperimental Cell Research, 1976
- Mitogenicity of thrombin and surface alterations on mouse splenocytesExperimental Cell Research, 1976
- Distribution of Cells Binding Erythrocyte‐Antibody (EA) Complexes in Human Lymphoid PopulationsScandinavian Journal of Immunology, 1976
- Suppression of RNA synthesis in lymphocytes by inhibitors of proteolytic enzymesExperimental Cell Research, 1974
- The effect of epsilon amino caproic acid and other inhibitors of proteolysis upon the response of human peripheral blood lymphocytes to phytohemagglutininJournal of Clinical Investigation, 1971
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962